Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABIVAX Société AnonymeADRS(ABVX) | 6,056,596 | 7,111,596 | +1,055,000 | $46.33M | $603.77M | 29.70% | +$557.44M |
| CG Oncology, Inc.COMM(CGON) | 3,670,206 | 3,670,206 | 0 | $95.43M | $147.84M | 7.27% | +$52.41M |
| Cogent Biosciences, Inc.COMM(COGT) | 6,964,375 | 6,798,162 | -166,213 | $50.00M | $97.62M | 4.80% | +$47.62M |
| Amylyx Pharmaceuticals, Inc.COMM(AMLX) | 5,943,812 | 6,243,812 | +300,000 | $38.10M | $84.85M | 4.17% | +$46.75M |
| Centessa Pharmaceuticals PlcADRS | 2,890,816 | 3,136,480 | +245,664 | $37.99M | $76.06M | 3.74% | +$38.07M |
| Tango Therapeutics, Inc.COMM(TNGX) | 10,736,000 | 8,536,196 | -2,199,804 | $54.97M | $71.70M | 3.53% | +$16.74M |
| Ocular Therapeutix, Inc.COMM(OCUL) | 5,319,148 | 6,117,232 | +798,084 | $49.36M | $71.51M | 3.52% | +$22.15M |
| Dianthus Therapeutics, Inc.COMM(DNTH) | 1,501,624 | 1,676,624 | +175,000 | $27.98M | $65.98M | 3.25% | +$38.00M |
| Tourmaline Bio IncCOMM | 1,477,593 | 1,311,783 | -165,810 | $23.63M | $62.74M | 3.09% | +$39.12M |
| Dyne Therapeutics, Inc.COMM(DYN) | 3,766,660 | 4,615,144 | +848,484 | $35.86M | $58.38M | 2.87% | +$22.52M |
| Agios Pharmaceuticals, Inc.COMM(AGIO) | 697,003 | 1,430,041 | +733,038 | $23.18M | $57.40M | 2.82% | +$34.22M |
| EyePoint, Inc.COMM(EYPT) | 3,572,335 | 3,572,335 | 0 | $33.62M | $50.87M | 2.50% | +$17.25M |
| Fulcrum Therapeutics, Inc.COMM(FULC) | 5,250,000 | 5,250,000 | 0 | $36.12M | $48.30M | 2.38% | +$12.18M |
| Savara Inc.COMM(SVRA) | 12,362,205 | 12,362,205 | 0 | $28.19M | $44.13M | 2.17% | +$15.95M |
| Rapt Therapeutics IncCOMM | 1,636,275 | 1,636,275 | 0 | $13.09M | $42.20M | 2.08% | +$29.11M |
| Tyra Biosciences, Inc.COMM(TYRA) | 2,898,103 | 2,898,103 | 0 | $27.73M | $40.54M | 1.99% | +$12.81M |
| Upstream Bio, Inc.COMM(UPB) | 2,801,763 | 2,117,103 | -684,660 | $30.76M | $39.82M | 1.96% | +$9.06M |
| Liquidia CorporationCOMM(LQDA) | 0 | 1,710,084 | +1,710,084 | $0 | $38.89M | 1.91% | +$38.89M |
| Disc Medicine, Inc.COMM(IRON) | 465,257 | 465,257 | 0 | $24.64M | $30.74M | 1.51% | +$6.10M |
| Structure Therapeutics IncADRS | 1,063,000 | 1,063,000 | 0 | $22.05M | $29.76M | 1.46% | +$7.72M |
| Xencor, Inc.COMM(XNCR) | 2,452,138 | 2,452,138 | 0 | $19.27M | $28.76M | 1.41% | +$9.49M |
| LB Pharmaceuticals IncCOMM(LBRX) | 0 | 1,745,016 | +1,745,016 | $0 | $27.55M | 1.36% | +$27.55M |
| Revolution Medicines, Inc.COMM(RVMD) | 0 | 436,473 | +436,473 | $0 | $20.38M | 1.00% | +$20.38M |
| Astria Therapeutics IncCOMM | 2,761,861 | 2,761,861 | 0 | $14.80M | $20.11M | 0.99% | +$5.30M |
| Korro Bio, Inc.COMM(KRRO) | 0 | 416,301 | +416,301 | $0 | $19.94M | 0.98% | +$19.94M |
| Kodiak Sciences Inc.COMM(KOD) | 1,145,538 | 1,145,538 | 0 | $4.27M | $18.75M | 0.92% | +$14.48M |
| Spyre Therapeutics, Inc.COMM(SYRE) | 0 | 1,100,582 | +1,100,582 | $0 | $18.45M | 0.91% | +$18.45M |
| Silence Therapeutics plcADRS(SLN) | 3,033,560 | 3,033,560 | 0 | $17.59M | $15.74M | 0.77% | -$1.85M |
| UroGen Pharma Ltd.COMM(URGN) | 0 | 717,347 | +717,347 | $0 | $14.31M | 0.70% | +$14.31M |
| Arvinas, Inc.COMM(ARVN) | 0 | 1,617,365 | +1,617,365 | $0 | $13.78M | 0.68% | +$13.78M |
| Monopar Therapeutics Inc.COMM(MNPR) | 0 | 153,000 | +153,000 | $0 | $12.50M | 0.61% | +$12.50M |
| MBX Biosciences, Inc.COMM(MBX) | 650,000 | 650,000 | 0 | $7.42M | $11.38M | 0.56% | +$3.96M |
| Vistagen Therapeutics, Inc.COMM(VTGN) | 2,676,580 | 2,676,580 | 0 | $5.35M | $9.50M | 0.47% | +$4.15M |
| Relay Therapeutics, Inc.COMM(RLAY) | 0 | 1,810,351 | +1,810,351 | $0 | $9.45M | 0.46% | +$9.45M |
| Adverum Biotechnologies IncCOMM | 1,796,482 | 1,668,174 | -128,308 | $3.86M | $7.56M | 0.37% | +$3.69M |
| Avalo Therapeutics, Inc.COMM(AVTX) | 483,000 | 483,000 | 0 | $2.41M | $6.14M | 0.30% | +$3.73M |
| ADC Therapeutics SACOMM(ADCT) | 0 | 1,390,175 | +1,390,175 | $0 | $5.56M | 0.27% | +$5.56M |
| PepGen Inc.COMM(PEPG) | 0 | 1,200,000 | +1,200,000 | $0 | $5.54M | 0.27% | +$5.54M |
| Entrada Therapeutics, Inc.COMM(TRDA) | 584,955 | 584,955 | 0 | $3.93M | $3.39M | 0.17% | -$538.2K |
| Ventyx Biosciences IncCOMM | 316,195 | 316,195 | 0 | $676.7K | $983.4K | 0.05% | +$306.7K |
| Cabaletta Bio, Inc.COMM(CABA) | 86,795 | 0 | -86,795 | $131.9K | $0 | — | -$131.9K |
| Cidara Therapeutics IncCOMM | 1,005,901 | 0 | -1,005,901 | $49.00M | $0 | — | -$49.00M |
| Enliven Therapeutics, Inc.COMM | 498,000 | 0 | -498,000 | $9.99M | $0 | — | -$9.99M |
| Jade Biosciences IncCOMM | 64,023 | 0 | -64,023 | $639.6K | $0 | — | -$639.6K |
| Keros Therapeutics, Inc.COMM(KROS) | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Kura Oncology, Inc.COMM(KURA) | 735,184 | 0 | -735,184 | $4.24M | $0 | — | -$4.24M |
| Nektar TherapeuticsCOMM(NKTR) | 266,666 | 0 | -266,666 | $6.89M | $0 | — | -$6.89M |
| Soleno Therapeutics IncCOMM | 186,250 | 0 | -186,250 | $15.60M | $0 | — | -$15.60M |
| Third Harmonic Bio IncCOMM | 1,915,424 | 0 | -1,915,424 | $10.40M | $0 | — | -$10.40M |